Introduced

Passed House

Passed Senate

Became law

Adjourned sine die. The bill was pending when the session ended, so it did not pass.

Last action · February 12, 2025

To Health Services (H)

Introduced February 6, 2025

House

Adjourned Sine Die

2025 Regular Session

HB384

AN ACT relating to intranasal epinephrine.

Amend KRS 158.832 to include intranasal epinephrine to list of medications used to treat anaphylaxis; amend KRS 158.836 to include intranasal epinephrine as permissible for schools to keep.

Education, Elementary and Secondary Health and Medical Services Children and Minors Drugs and Medicines

Read the full text Kentucky Legislature LegiScan

AI-generated. Always verify with primary sources

Plain-language summary

Beta

This bill would update Kentucky school health law to add intranasal epinephrine, a medication delivered through the nose, to the list of approved treatments for severe allergic reactions. It would also allow schools to keep intranasal epinephrine on hand alongside other anaphylaxis medications they are already permitted to stock. Who it may affect: students and school staff, particularly those at risk for severe allergic reactions.

Open official bill text (PDF)·Report a problem with the summary